MCRB Valuation

Seres Therapeutics Inc (MCRB) has a current Price-to-Book (P/B) ratio of 3.40. Compared to its 3-year average P/B ratio of 6.04 , the current P/B ratio is approximately -43.70% higher. Relative to its 5-year average P/B ratio of 7.75, the current P/B ratio is about -56.16% higher. Seres Therapeutics Inc (MCRB) has a Forward Free Cash Flow (FCF) yield of approximately -15.25%. Compared to its 3-year average FCF yield of -73.35%, the current FCF yield is approximately -79.21% lower. Relative to its 5-year average FCF yield of -47.05% , the current FCF yield is about -67.59% lower.